Complete, long-standing regression of hepatocellular carcinoma after somatostatin analogue treatment

Print
Published on Friday, 13 December 2013

Complete, long-standing regression of hepatocellular carcinoma after somatostatin analogue treatment.

 

 

About this Letter/Article.